LEADER 01192nam  2200301z- 450 
001 9910689449703321
005 20161209100751.0
035   $a(CKB)5860000000026159
035   $a(BIP)007967310
035   $a(EXLCZ)995860000000026159
100   $a20220406c2001uuuu  -u-         -
101 0 $aeng
200 10$aHuman subject research protections $ehearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Sixth Congress, second session, May 3, 2000
215   $a1 online resource (iii, 171 p.) 
311   $a0-16-065646-X 
517   $aHuman Subject Research Protections
606   $aHuman experimentation in medicine$xGovernment policy$zUnited States
606   $aClinical trials$xGovernment policy$zUnited States
610   $aHuman experimentation in medicine
610   $aClinical trials
610   $aMedicine
610   $aMedical
615  0$aHuman experimentation in medicine$xGovernment policy
615  0$aClinical trials$xGovernment policy
906   $aBOOK
912   $a9910689449703321
996   $aHuman subject research protections$93096306
997   $aUNINA